(Q38169067)

30 August 2017

1 reference

title

Pharmacology of platelet inhibitors (English)

1 reference

30 August 2017

1 reference

L A Harker

1

1 reference

30 August 2017

V Fuster

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Journal of the American College of Cardiology

30 August 2017

published in

1 reference

30 August 2017

volume

8

1 reference

30 August 2017

issue

6 Suppl B

1 reference

30 August 2017

page(s)

21B-32B

1 reference

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet and fibrinogen consumption in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Molecular defects in interactions of platelets with the vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Diglyceride lipase: a pathway for arachidonate release from human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Production of diglyceride from phosphatidylinositol in activated human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The functioning of blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Interrelations of Platelet Aggregation and Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet Interaction with Polymerizing Fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chain

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphate-induced platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Stimulation of Endothelial Cell Prostacyclin Production by Thrombin, Trypsin, and the Ionophore A 23187

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

1 reference

7 January 2021

Cyclic AMP and platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Role of platelet activation and fibrin formation in thrombogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The bleeding time as a screening test for evaluation of platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Increased Platelet Aggregates in Patients With Transient Ischemic Attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Inhibition of platelet prostaglandin synthetase by oral aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Recovery of Endothelial Cell Prostacyclin Production after Inhibition by Low Doses of Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Aspirin and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Aspirin inhibits platelet aggregation on, but not adhesion to, collagen fibrils: an assessment of platelet adhesion and deposited platelet mass by morphometry and 51Cr-labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Vasoconstriction: a new activity for platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet accumulation in the myocardium during acute nonthrombotic coronary artery occlusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

: A selective inhibitor of thromboxane synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Prostaglandins I2 and E1 reduce rabbit and human platelet adherence without inhibiting serotonin release from adherent platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Anti-platelet action of intravenous infusion of prostacyclin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Prostacyclin can replace heparin in haemodialysis in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Renal actions of prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet Adherence to the Vessel Wall and to Collagen-Coated Surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet survival in patients with substitute heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Membranoproliferative Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Heparin, antithrombin, and abnormal clotting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effect of Heparin and Heparin Fractions on Platelet Aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The separation of active and inactive forms of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Heparin Neutralization of PGI 2 : Effects Upon Platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effects of sulfinpyrazone on early graft closure after myocardial revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

The influence of antiplatelet drugs on platelet survival after aortic damage or implantation of a dacron arterial prothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effects of cephalothin and penicillin G on platelet function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Carbenicillin and Penicillin G Inhibit Platelet Function In Vitro by Impairing the Interaction of Agonists with the Platelet Surface

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

THE EFFECT OF DEXTRAN ON PLATELET FACTOR 3 ACTIVITY: IN VITRO AND IN VIVO STUDIES

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Effect of dextran 70 on factor VIII and platelet function in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Antithrombotic activity of suloctidil

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Vitamin E. An inhibitor of the platelet release reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

Vitamin E inhibits the release of calcium from a platelet membrane fraction in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980004-3

7 January 2021

10.1016/S0735-1097(86)80004-3

Identifiers

DOI

1 reference

release_65inicjsizc6lcfvti4auysqr4

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/65inicjsizc6lcfvti4auysqr4

24 November 2022

mapped directly with Wikidata item

1 reference